Adjusting to change in healthcare: Learning from translational research

Martine Leroy|30th March 2016

Healthcare is undergoing a transformative change, which presents challenges to all players in the sector. Factors of change include evolving expectations and requirements from populations and governments, and newcomers to the field that are changing both supply and demand. Established healthcare players like pharma need to control and shape their emerging roles.

In this respect, pharma needs to be more pro-active if it is to strengthen and enhance its role. Its efforts to date seem quite timid.

Translational research organisations are healthcare players who are adjusting their strategies in anticipation of change, thus turning challenges into opportunities. What if pharma learned how to adapt faster and more effectively from these organisations?

Head of Insight Martine Leroy explores this ‘what if’ scenario, outlining the ways that pharma could learn from translational research organisations and improve their approach to the changing healthcare landscape.

Translational research organisations are adjusting their strategy

In the UK, the National Health System (NHS) is a major factor of change in that it places engagement and responsibility of the population in their own health and care at the centre of its policy. This is focusing the transformation of the healthcare landscape on cost-effective, positive patient outcomes. Translational research organisations are responding by adjusting their strategies to align with the NHS, to contribute to delivering better patient outcomes, faster.

Traditionally, the role of translational research is to increase the volume of basic scientific discovery that goes into clinical research and hopefully, become real clinical innovation. This is because historically, there is a waste of basic scientific learning that goes into clinical research, because of lack of focus and funding, amongst other factors. 

 

Download the full article by clicking the button below.

Empowering the MS patient through shared decision making

Guest Blogger|25th April 2019

Patient advocate Trishna Bharadia explains why shared decision making is crucial for ensuring multiple sclerosis patients feel heard and empowered

read more

My MS journey: one patient's search for innovation

Guest Blogger|18th April 2019

David Lazarus charts his journey from initial MS diagnosis in 1990 to his experience participating in innovative clinical trials, along with his advice for other patients.

read more

MIT reveals new pill to deliver insulin

Dina Patel|10th April 2019

A new MIT research project, sponsored by Novo Nordisk, is aiming to deliver insulin orally with a pill that releases medicine in the stomach lining. Dina Patel interviews the team and reveals the innovative engineering behind the pill. 

read more